Close

Burning Rock’s Liquid Biopsy Assay Achieved Strong Performance in the FDA-led SEQC2 Study, with Results Published on Nature Biotechnology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. NVDA
4. META
5. PPG
6. HDFCB:IN
7. HDB
8. WIT
9. MSFT
10. HDFCAMC:IN


Go back to Burning Rock’s Liquid Biopsy Assay Achieved Strong Performance in the FDA-led SEQC2 Study, with Results Published on Nature Biotechnology
(NASDAQ: BNR) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $ 
Open $0.86    52 Week Low $ 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $ 
Volume 88